MedPath

JHMC registry study

Not Applicable
Conditions
meningioma
Registration Number
JPRN-jRCT1030220128
Lead Sponsor
Oya Soichi Soichi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Patients with recurrent WHO grade 1 meningioma or WHO grade 2/3 meningioma who have undergone surgical resection at participating institutions from 2001 to the start of this study , who have completed the necessary medical examinations, whose residual specimens are stored, and who have already given consent for use in medical research in general, including genetic analysis, are included in this study.
The patients who have already given consent for the use of their specimens for genetic analysis and other medical research are also included in the study.
In addition, patients with newly diagnosed recurrent WHO grade 1 meningioma or WHO grade 2/3 meningioma who have undergone resection after the start of this study at the participating institutions are included if their consent for use in this study has been obtained at each institution for the remaining specimens after all necessary tests for treatment have been performed. Blood samples will also be collected from patients who fall into any of the above categories and who consent to have their blood samples collected.

Exclusion Criteria

Patients for whom consent for participation in the study described in 9. Methods of Obtaining Subjects' Understanding and Consent in the research protocol can not be obtained are excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath